Shiferaw Melashu Balew, Yismaw Gizachew, Getachew Hailu
Amhara Public Health Institute, P.O.Box 447, Bahir Dar, Amhara, Ethiopia.
BMC Res Notes. 2018 Nov 1;11(1):781. doi: 10.1186/s13104-018-3891-7.
The aim of this study was to assess the magnitude, trend and reasons of rejection among referred specimens through referral network to the Amhara Public Health Institute (APHI) for laboratory testing.
A total of 42,923 specimens were received at APHI reference laboratories. Of which, 221 (0.5%) specimens were rejected. CD4, HIV viral load, genexpert and EID specimens' rejection rates were 0.7%, 0.6%, 0.3% and 0.2%, respectively. CD4 specimens were rejected due to wrong package (84.2%) and presence of clots (15.8%). Un-centrifuge (46.9%), hemolysis (19.8%) and use of wrong tube (17.7%) were the main rejection reasons for HIV viral load specimens. Although viral load specimen rejection was improved from 1.8 to 0% up to February/2018, the problem was reoccurred and continued to the end of May (1.3%) and June (0.3%) 2018. Moreover, CD4 specimen rejection (4.3%) was out of the established target in May, and exposed infant diagnosis (EID) specimen rejection became increased since March 2018. Hence, appropriate corrective and preventive actions and close follow up could reduce the problem of specimen referral network.
本研究旨在评估通过转诊网络转至阿姆哈拉公共卫生研究所(APHI)进行实验室检测的送检标本的拒收幅度、趋势及原因。
APHI参考实验室共接收了42,923份标本。其中,221份(0.5%)标本被拒收。CD4、HIV病毒载量、基因专家检测和暴露婴幼儿诊断(EID)标本的拒收率分别为0.7%、0.6%、0.3%和0.2%。CD4标本被拒收的原因是包装错误(84.2%)和存在凝块(15.8%)。未离心(46.9%)、溶血(19.8%)和使用错误试管(17.7%)是HIV病毒载量标本的主要拒收原因。尽管截至2018年2月病毒载量标本拒收率从1.8%降至0%,但该问题再次出现,并持续到2018年5月底(1.3%)和6月(0.3%)。此外,5月份CD4标本拒收率(4.3%)超出既定目标,自2018年3月以来暴露婴幼儿诊断(EID)标本拒收率有所上升。因此,采取适当的纠正和预防措施并密切跟进可减少标本转诊网络的问题。